Sponsor Pipeline

BioMarin Pharmaceutical Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
20
Active Trials
8
Recruiting
4
Phase 3
2
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-30 NCT07441876
Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With…
Trial sites expanded: 4 -> 10 locations
Active Trials by Phase
Phase 4
2
Phase 3
3
Phase 2/3
1
Phase 2
7
Phase 1/2
1
Phase 1
1
Not specified
5
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07477691 Immune Modulation During Palynziq® Treatment in Adults (IMPALA) Phenylketonuria Not Yet Recruiting
NCT06780332 Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to… Phenylketonuria Active, Not Recruiting
Phase 3
NCT06455059 Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia Hypochondroplasia Active, Not Recruiting
NCT03424018 An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With… Achondroplasia Active, Not Recruiting
NCT06224907 Phase 3 Study for Efficacy and Safety Outcomes Data in Japanese Patients With Severe… Hemophilia A Active, Not Recruiting
Phase 2/3
NCT07441876 Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With… Achondroplasia Recruiting
Phase 2
NCT07126262 A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36… Hypochondroplasia Recruiting
NCT06668805 A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or… Noonan Syndrome Recruiting
NCT06382155 A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature Idiopathic Short Stature Recruiting
NCT02724228 A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children… Achondroplasia Active, Not Recruiting
NCT03989947 An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With… Achondroplasia Active, Not Recruiting
NCT04554940 A Clinical Trial to Evaluate Safety of Vosoritide in At-risk Infants With Achondroplasia Achondroplasia Active, Not Recruiting
NCT07573631 An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in… Duchenne Muscular Dystrophy (DMD) Enrolling by Invitation
Phase 1/2
NCT06280209 A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and… Duchenne Muscular Dystrophy Recruiting
Phase 1
NCT06738017 Study of BMN 349 Single Dose in PiZZ and PiMZ/MASH Adult Participants Alpha 1-Antitrypsin Deficiency Active, Not Recruiting
Not specified
NCT05579548 A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to… Phenylketonuria, Maternal Recruiting
NCT06305234 A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq… Phenylketonuria (PKU) Recruiting
NCT05813678 A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace) Phenylketonuria (PKU) Recruiting
NCT05768386 A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a… Hemophilia A Enrolling by Invitation
NCT04476862 Cerliponase Alfa Observational Study in the US Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 Active, Not Recruiting
Disease Areas
Get alerts when BioMarin Pharmaceutical's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free